[Incompatibility and interference of the major cardiologic drugs. Their undesirable effects].
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced; D002301:Cardiac Glycosides / Q000009:adverse effects*; D004071:Digitalis Glycosides / Q000009:adverse effects; D004206:Disopyramide / Q000009:adverse effects; D004347:Drug Interactions; D004357:Drug Synergism; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007008:Hypokalemia / Q000139:chemically induced; D007545:Isoproterenol / Q000009:adverse effects; D008012:Lidocaine / Q000009:adverse effects; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D010042:Ouabain / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011299:Prenylamine / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects; D011802:Quinidine / Q000009:adverse effects
D000889:Anti-Arrhythmia Agents; D000893:Anti-Inflammatory Agents; D000959:Antihypertensive Agents; D002301:Cardiac Glycosides; D004071:Digitalis Glycosides; D008996:Monoamine Oxidase Inhibitors; D010042:Ouabain; D010672:Phenytoin; D008012:Lidocaine; D004206:Disopyramide; D011802:Quinidine; D011299:Prenylamine; D011342:Procainamide; D007545:Isoproterenol
Incompatibilités et interférences dés grandes médications cardiologiques. Leurs effets indésirables